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Summary
 
Previous studies have shown that autoimmune thyroiditis can be induced in normal laboratory
 
rats after thymectomy and split dose 
 
g
 
-irradiation. Development of disease can be prevented
by reconstitution of PVG rats shortly after their final irradiation with either peripheral
CD4
 
1
 
CD45RC
 
2
 
 T cells or CD4
 
1
 
CD8
 
2
 
 thymocytes from syngeneic donors. Although the ac-
tivity of both populations is known to depend on the activities of endogenously produced in-
terleukin 4 and transforming growth factor 
 
b
 
, implying a common mechanism, the issue of an-
tigen specificity of the cells involved has not yet been addressed. In this study, we show that the
regulatory T cells that prevent autoimmune thyroiditis are generated in vivo only when the
relevant autoantigen is also present. Peripheral CD4
 
1
 
 T cells, from rats whose thyroids were
ablated in utero by treatment with 
 
131
 
I, were unable to prevent disease development upon
adoptive transfer into thymectomized and irradiated recipients. This regulatory deficit is spe-
cific for thyroid autoimmunity, since CD4
 
1
 
 T cells from 
 
131
 
I-treated PVG.RT1
 
u
 
 rats were as
effective as those from normal donors at preventing diabetes in thymectomized and irradiated
PVG.RT1
 
u
 
 rats. Significantly, in contrast to the peripheral CD4
 
1
 
 T cells, CD4
 
1
 
CD8
 
2
 
 thy-
mocytes from 
 
131
 
I-treated PVG donors were still able to prevent thyroiditis upon adoptive
transfer. Taken together, these data indicate that it is the peripheral autoantigen itself that stim-
ulates the generation of the appropriate regulatory cells from thymic emigrant precursors.
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T
 
here is compelling evidence that the immune system is
controlled by populations of T cells whose function is
to inhibit the activation of T cells that are potentially dan-
gerous to the host. These regulatory T cells (T
 
reg
 
) have
been described in the prevention of inflammatory responses
to dietary antigens (1, 2) and in the control of autoimmu-
nity (3–6). The mode of action of these protective cells is
not well understood, but a knowledge of their antigen spec-
ificity is an essential prerequisite for such understanding.
Studies of T
 
reg
 
 in our own laboratory have exploited two
different inducible models of autoimmunity. Autoimmune
thyroiditis and insulin-dependent diabetes mellitus (IDDM)
are induced in PVG.RT1
 
c
 
 (hereafter PVG) and PVG.RT1
 
u
 
strain rats, respectively, by similar protocols of thymectomy
and split dose 
 
g
 
-irradiation (TxX) (7, 8). Although both
diseases are similarly induced, they are characterized by
contrasting autoimmune processes. IDDM in PVG.RT1
 
u
 
rats involves a CD8
 
1
 
 T cell–dependent cell-mediated
pathogenesis, whereas thyroiditis development in PVG rats
results in high titers of Th2-associated IgG1 isotype anti-
thyroglobulin (Tg) antibodies and does not require CD8
 
1
 
 T
cells. However, in both cases, development of disease can
be prevented by reconstitution of rats with either peripheral
CD4
 
1
 
 T cells or mature CD4
 
1
 
CD8
 
2
 
 thymocytes (8–10),
and, at least in the prevention of thyroiditis, the suppressive
 
activity of both subsets is dependent on IL-4 and TGF-
 
b
 
.
The T
 
reg
 
 in the periphery that prevent autoimmunity are
found exclusively among cells with a resting memory phe-
notype (CD4
 
1
 
CD45RC
 
2
 
TCR-
 
a/b
 
1
 
RT6
 
1
 
) (8). Although
it has been shown that the thymus is a potent source of T
 
reg
 
(9, 10), the observation that the peripheral cells have a
primed phenotype suggests that recognition of specific an-
tigen in the periphery is an essential developmental step.
However, the identity of the antigen(s) is not known. Data
from studies of oophoritis and prostatitis that develop in
certain mice strains after thymectomy between 2 and 4 d
after birth implicate a role for tissue specific antigens in the
generation of T
 
reg
 
, since CD4
 
1
 
 T cells from mice lacking
the relevant organs, either due to gender or surgical re-
moval, are less effective at preventing disease development
(11, 12). However, these data remain contentious since
other studies report contradictory results (13) and it is pos-
sible that gender-specific organs still share tissue-specific
antigens that may be the target of regulatory activity.
The aim of our study was to test the hypothesis that the
encounter of T
 
reg
 
 with peripheral self-antigen is essential 
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for their successful development. To address this question,
rats were generated in which the thyroid gland had been
completely ablated by treatment with 
 
131
 
I in utero before
significant export of T cells from the thymus had occurred
(14). The data from this study show that T cells from these
athyroid rats were selectively unable to prevent thyroid-
specific autoimmunity while retaining the capacity to pre-
vent autoimmune diabetes. In contrast, CD4
 
1
 
CD8
 
2
 
 thy-
mocytes from the same athyroid donors were as effective as
those from normal rats at preventing thyroiditis. Implica-
tions for the development of T
 
reg
 
 and the possibility for
therapeutic intervention in this process are discussed.
 
Materials and Methods
 
mAbs.
 
The mouse mAbs used in these studies were as fol-
lows: OX6 (anti–rat class II MHC; reference 15), OX7 (anti–rat
Thy-1; reference 16), OX8 (anti–rat CD8; reference 17), and
OX12 (anti–rat 
 
k 
 
chain; reference 18).
 
Animals and Induction of Thyroiditis and Diabetes.
 
3–12-wk-old
female PVG and PVG.RT1
 
u
 
 rats, which differ only in their
MHC haplotype, were obtained from the specific pathogen-free
breeding facilities of the Medical Research Council Cellular Im-
munology Unit (Oxford, UK). Thyroiditis was induced in female
PVG rats as has been previously described (7). In brief, female rats
aged 3 wk were thymectomized and given four 275-rad doses of
 
137
 
Cs 
 
g
 
-irradiation at 2-wk intervals starting 1 wk after thymec-
tomy. Development of thyroiditis was determined histologically
and by the development of anti-Tg antibodies. Diabetes was in-
duced in male PVG.RT1
 
u
 
 rats by their thymectomy at 6 wk of
age followed by four 250-rad doses of 
 
137
 
Cs 
 
g
 
-irradiation at 2-wk
intervals starting 2 wk after thymectomy. Development of diabe-
tes was determined by monitoring body weight and blood glu-
cose levels.
 
Ablation of Rat Thyroid Glands.
 
Fetal PVG and PVG.RT1
 
u
 
rats were exposed to 
 
131
 
I (Amersham International plc., UK) at
day 18 of gestation by intraperitoneal injection of the mother
with 2 mCi of the radioactive isotope. The success of the ablation
was determined both histologically and by assaying serum thy-
roid-stimulating hormone (TSH) levels by radio immunoassay
(Amersham International plc.) in 8-wk-old treated rats.
 
Isolation of T Cell Subpopulations.
 
Mature rat CD4
 
1
 
 T lym-
phocytes were negatively selected from lymph node and spleen
cells using magnetic beads (Dynal, Norway) by depletion of B cells,
CD8
 
1
 
 T cells, and recent thymic emigrants using the mAbs OX12,
OX8, OX7, and OX6. CD4
 
1
 
CD8
 
2
 
 thymocytes were similarly
purified from thymus by depletion of CD8
 
1
 
 cells. The purity of all
isolated cells, analyzed on a FACScan
 
®
 
 by labeling pre- and postde-
pletion samples with rabbit anti–mouse Ig FITC, was 
 
.
 
98%.
 
Detection and Quantitation of Anti-Tg Antibodies in Sera of
Rats.
 
Sera from TxX rats were assayed by specific ELISA using
96-well microtiter plates coated overnight with purified rat Tg
(20 
 
m
 
g/ml). After incubation of serial dilutions of sera from indi-
vidual rats for 2 h at room temperature, bound rat IgG was de-
tected using anti–rat IgG alkaline phosphatase conjugate (Sigma
Chemical Co.) for 1 h at room temperature. The assay was devel-
oped using enzyme substrate 4-nitro-phenyl phosphate (5 mg/ml;
Sigma Chemical Co.) for 15 min at room temperature before
reading the OD at 405 nm. Anti-Tg antibody titers were quanti-
fied by comparison with a standard serum pooled from TxX rats
with thyroiditis and high anti-Tg antibody titers and expressed as
a percentage of this standard. The level of nonspecific binding
 
found in normal PVG serum represented a titer of 
 
z
 
0.1% in the
assay, and therefore only sera with titers 
 
.
 
0.3% were considered
to contain specific anti-Tg antibodies.
 
Histological Analysis.
 
Whole thyroids attached to thyroid car-
tilage were dissected out and fresh-frozen in O.C.T. embedding
medium (Sakura Finetek U.S.A. Inc.). 10-
 
m
 
m sections were cut
from frozen blocks and stained with hematoxylin and eosin.
 
Results and Discussion
 
Athyroid rats were generated after a modification of a
previously described protocol using 
 
131
 
I (19). Rats were
treated in utero with 
 
131
 
I on day 18 of gestation by inject-
ing the pregnant mother with 2 mCi of the isotope into the
peritoneal cavity. Serial sections of thyroid cartilage from
8-wk-old 
 
131
 
I-treated rats revealed extensive destruction of
glands with little or no follicular thyroid tissue apparent
(Fig. 1 B). The success of the ablation was confirmed by
the detection of high levels of TSH in serum of treated an-
imals. Thyroxine normally exerts negative feedback inhibi-
tion of TSH production via the hypothalamic-pituitary
axis, such that in the absence of thyroxine TSH levels are
allowed to increase unchecked. Serum TSH levels in PVG
or PVG.RT1
 
u
 
 rats treated with 
 
131
 
I in utero were 
 
.
 
10
times higher than those of normal rats (Table I).
To determine whether thyroid antigen–specific T
 
reg
 
function had been affected by ablation of thyroid glands,
CD4
 
1
 
 T cells from these rats were assayed for their ability
to regulate thyroid-specific autoimmunity by their adoptive
transfer into TxX PVG rats before development of thy-
roiditis. Although the protective capacity of CD4
 
1
 
 T cells
has been shown previously to be mediated entirely by the
CD45RC
 
2
 
 subset (8, 10), unfractionated CD4
 
1
 
 T cells
were assayed because, at least in principle, it was possible
that in the absence of specific thyroid antigen in 
 
131
 
I-treated
rats, T
 
reg
 
 would still be functional but assume a naive
CD4
 
1
 
CD45RC
 
1
 
 phenotype. Autoimmune thyroiditis was
induced in PVG rats by their thymectomy at 3 wk of age
followed by four doses of 275 rad 
 
137
 
Cs 
 
g
 
-irradiation at 2 wk
intervals starting 1 wk after thymectomy. Groups of these
rats were reconstituted shortly after the final irradiation
 
Table I.
 
Serum TSH Levels of 8-wk-old Normal PVG Rats and 
Rats Treated with 
 
131
 
I In Utero
 
Treatment
Serum TSH
ng/ml 
 
6 
 
SD Range
 
n
 
None 7.7 
 
6
 
 1.4 5.8–10.2 7
 
131
 
I-treated PVGs 116.7 
 
6
 
 52.3 54.6–200.5 10
 
131
 
I-treated PVG.RT1
 
u
 
 rats 171.8 
 
6
 
 29.8 128.5–199.2 6
All 
 
131
 
I-treated rats 137.4 
 
6
 
 52 54.6–200.5 16
Pregnant PVG and PVG.RT1
 
u
 
 rats were injected intraperitoneally with
2 mCi of 
 
131
 
I on day 18 of gestation. Offspring of 
 
131
 
I-treated and nor-
mal untreated PVG rats were bled at 8 wk of age and serum TSH con-
centration was determined by RIA. 
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with either 5 
 
3 
 
10
 
6
 
 CD4
 
1
 
CD8
 
2
 
 thymocytes or 10
 
7
 
 CD4
 
1
 
peripheral T cells purified from either normal or athyroid
8-wk-old PVG rats. Consistent with previous studies, a
highly significant proportion of rats reconstituted with
CD4
 
1
 
CD8
 
2
 
 thymocytes or CD4
 
1
 
 T cells from normal rats
were protected from development of both serological (Fig.
2 A) and histological (Fig. 1 D) signs of disease. In contrast,
TxX rats reconstituted with CD4
 
1
 
 T cells from athyroid
rats developed high titers of anti-Tg antibody (Fig. 2 A)
and had extensive leukocytic infiltration of thyroid glands
(Fig. 1 F). Significantly, CD4
 
1
 
CD8
 
2
 
 thymocytes from the
same athyroid rats were as effective as the same population
from normal rats at preventing development of thyroiditis
(Figs. 1 E and 2 A).
One possible explanation for the failure of CD4
 
1
 
 T cells
from athyroid rats to control thyroiditis was that the thy-
roxine deficiency that resulted from 
 
131
 
I treatment may
have had an adverse effect on either thymopoiesis, and
therefore normal repertoire selection, or on peripheral T
cell function including that of T
 
reg
 
. Therefore, to test both
the specificity of the regulatory deficit and the impact of
thyroxine deficiency on T
 
reg
 
 function, the ability of T cells
from athyroid rats to prevent autoimmunity was assayed in
a second autoimmune model not involving thyroid anti-
gens. PVG.RT1
 
u rats were induced to develop insulin-
dependent diabetes by a similar protocol of thymectomy
and split dose g-irradiation. Shortly after the final irradia-
tion, rats were reconstituted with 107 CD41 peripheral T
cells from either normal or athyroid syngeneic donors. Sig-
nificantly, the level of protection from diabetes afforded to
TxX PVG.RT1u rats reconstituted with 107 CD41 T cells
from athyroid syngeneic donors was almost identical to that
Figure 1. Morphology of thyroid glands in 131I-treated rats and TxX
rats with thyroiditis. Pregnant PVG rats were injected intraperitoneally
with 2 mCi of 131I on day 18 of gestation. Thyroid cartilage and attached
tissue was removed from normal PVG rats (A) and 131I-treated rats (B) at
8 wk of age, sectioned and stained with hematoxylin and eosin. In the
same series of experiments as those described in Fig. 2, whole thyroid
glands attached to thyroid cartilage were taken at the time of peak disease
from control TxX PVG rats (C), recipients of 107 CD41 T cells from
normal PVG rats (D), and recipients of either 5 3 106 CD41CD82 thy-
mocytes (E) or 107 CD41 T cells (F) from the same athyroid donors.
Thyroids were frozen, sectioned, and stained with hematoxylin and eosin
and are shown at low magnification. (Original magnification: 350.)
Figure 2. Adoptive transfer of peripheral CD41 T cells from athyroid
donors into TxX rats prevents development of diabetes but not thyroid-
itis. Athyroid donor PVG and PVG.RT1u rats were generated after expo-
sure to 131I in utero as described in Fig. 1. Normal PVG and PVG.RT1u
rats were thymectomized at 3 and 6 wk of age, respectively, and given
1,100 and 1,000 rads of split dose g-irradiation, respectively, in four equal
doses at 2-wk intervals. Shortly after the last irradiation, groups of TxX
PVG rats were reconstituted with 5 3 106 CD41CD82 thymocytes puri-
fied from the thymus of either normal or athyroid 8-wk-old PVG donor
rats. Further groups of TxX PVG rats were reconstituted with 107 CD41
T cells purified from the same normal and athyroid PVG donors. Devel-
opment of anti-Tg IgG responses was monitored for between 4 and 12
wk after the last irradiation by specific ELISA. Data represent peak anti-
Tg IgG titers of individual TxX rats, expressed as percentage of standard
(A). TxX PVG.RT1u rats were reconstituted shortly after their final irra-
diation with 107 CD41 T cells purified from either normal or athyroid
8-wk-old PVG.RT1u rats. The disease incidence of thyroiditis in groups
of TxX PVG rats (B) and diabetes in groups of TxX PVG.RT1u rats (C)
reconstituted with different cell subsets from different donors are ex-
pressed as a percentage of the group. Numbers in parentheses show the
actual incidence and group sizes. P values were calculated using Fisher’s
exact test.880 Peripheral Autoantigen Induces Regulatory T Cells
observed in recipients of 107 CD41 T cells from age-
matched euthyroid controls. Approximately 50% of recipi-
ents were protected in both cases (Fig. 2 C), a level of pro-
tection essentially the same as that observed in previous
studies (8). Furthermore, that intrathymic generation of
Treg was not adversely affected by thyroxine deficiency in
131I-treated rats was evident from the observation that
CD41CD82 thymocytes from these rats were able to pre-
vent thyroiditis in TxX PVG rats.
The most economical interpretation of these data is that
peripheral autoantigen is itself responsible for the induction
of Treg, and although other interpretations are possible, Treg
appear to express TCRs specific for the relevant autoanti-
gen. Athyroid rats were deficient only in Treg that control
thyroid targeted autoimmunity, since cells from these rats
could still suppress diabetes (Fig. 2, B and C). Such obser-
vations are compatible with others studies of thyroid au-
toimmunity that result after removal of thyroids during
gestation, either surgically or by 131I ablation. Bilateral thy-
roidectomy but not hemithyroidectomy of lambs at 52 d of
gestation results in a loss of self-tolerance to the same thy-
roid glands, retransplanted after their storage in nude mice
(20). Similarly, rats exposed to 131I in utero reject syngeneic
thyroid grafts as adults (19). However, when thyroid-
ablated rats are surgically parabiosed with normal, syn-
geneic partners, self-tolerance to thyroid transplantation is
restored (21). These results provide further evidence impli-
cating a role for peripheral self-antigen in the generation of
specific Treg. Experiments with Treg in mice, which prevent
skin allograft rejection, are also compatible with this inter-
pretation (22).
The observation of this study that CD41CD82 thy-
mocytes from athyroid rats retain the capacity to prevent
thyroiditis, in stark contrast to their peripheral counter-
parts, has implications regarding the lineage development
of these regulatory cells. Earlier studies demonstrated that
CD41CD82 thymocytes are a more potent source of Treg
than are peripheral CD41 T cells (9) and that this is un-
likely to be attributed to differences in their mechanism of
action, since protection from disease is dependent on IL-4
and TGF-b in both cases (10). One interpretation of these
data is that maturation of Treg from thymic emigrants into
the mature peripheral Treg population is subject to strict ho-
meostatic regulation, such that only as many Treg undergo
peripheral maturation as are required to suppress the activ-
ity of autoreactive T cells in the repertoire. Under condi-
tions where the Treg pool has been perturbed, as occurs
during the induction of autoimmunity in TxX rats, such a
mechanism would stimulate the differentiation of all poten-
tial precursors among CD41CD82 thymocytes. Since ma-
ture peripheral Treg have already undergone differentiation,
no further recruitment is possible, and it is this difference in
plasticity of the regulatory populations that results in the
apparent potency of thymocytes compared with peripheral
cells. That CD41CD82 thymocytes from athyroid rats are
able to prevent disease development shows that intrathymic
generation of Treg during repertoire selection does not re-
quire peripheral thyroid tissue. Thymocytes from these an-
imals have the potential to mature into specific Treg, but in
the absence of peripheral antigen fail to do so. However,
adoptive transfer of these cells into euthyroid TxX rats res-
cues Treg development and in doing so protects the recipi-
ents from disease development. These data suggest that the
requirement for self-antigen in Treg maturation is also the
point of homeostatic control, raising the possibility that it is
the Treg themselves that regulate their own differentiation.
With regard to the fate of the Treg precursor that emerges
from the thymus of athyroid rats in the absence of autoanti-
gen, it is not possible to conclude whether the regulatory
deficit in these rats results from a failure of these cells to ex-
pand to a functionally significant frequency or a failure of
the cells to survive in the absence of autoantigen.
The finding that the thymus is a potent source of Treg
(9), together with the observation that mRNA for many “tis-
sue-specific” autoantigens, including insulin and thyroglo-
bulin, can be detected intrathymically (23–25) is suggestive
of a role for positive selection of the T cell repertoire on
self-antigens in the generation of Treg. There is some evi-
dence that the self-antigens that mediate positive selection
are antagonist peptides (26, 27). Significantly, recognition
of synthetic antagonistic peptide has been shown in several
studies to affect cytokine production, notably that of TGF-b
(28). This raises the possibility that peripheral T cell recog-
nition of the autoantigen on which they were selected in-
trathymically induces generation of Treg and evokes a regu-
latory response from them that acts to specifically suppress
autoimmune responses (6).
Finally, previous studies suggest that there exists in the T
cell repertoire a fine balance between autoreactive T cells
and the Treg that control them (9). Thus, any adverse per-
turbation of this balance, either congenital or environmen-
tal, could result in autoimmunity. The conclusion of this
study, that peripheral autoantigen is responsible for the in-
duction of specific Treg from precursors found in abun-
dance amongst mature thymocytes, raises the possibility of
augmenting the physiological process with a therapeutic
outcome. In principle, administration of autoantigens in an
appropriate form may have the effect of increasing the in-
duction of Treg and as such represent a basis for vaccination
against autoimmune disease.
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